His primary scientific interests are in Immunology, Antibody, Monoclonal antibody, Cancer research and Molecular biology. In his study, Isotype is strongly linked to Cytotoxicity, which falls under the umbrella field of Antibody. His Monoclonal antibody research includes elements of Glycoprotein, Ganglioside, Neuroblastoma and Antigen.
In Antigen, Ralph A. Reisfeld works on issues like Biochemistry, which are connected to Chromatography. His Cancer research research incorporates elements of Cancer and Metastasis. His biological study spans a wide range of topics, including Proteoglycan, Chondroitin sulfate proteoglycan, Cell culture and Cell adhesion.
His primary areas of investigation include Immunology, Antigen, Molecular biology, Antibody and Cancer research. His Immunology study frequently draws connections between related disciplines such as Melanoma. His Antigen research includes themes of Cytotoxic T cell, Pan-T antigens and Biochemistry, Glycoprotein.
The study incorporates disciplines such as Cytolysis, Cytokine and Fusion protein in addition to Antibody. His Cancer research research incorporates themes from Cancer, Metastasis and In vivo. His Immunotherapy research is multidisciplinary, relying on both T cell and Neuroblastoma.
Ralph A. Reisfeld mainly focuses on Cancer research, Immunology, Immunotherapy, DNA vaccination and Angiogenesis. His study in Cancer research is interdisciplinary in nature, drawing from both Cancer, Metastasis and Cytotoxic T cell. His research ties Neuroblastoma and Immunology together.
The Neuroblastoma study combines topics in areas such as Oncology, Phases of clinical research, Internal medicine, Interleukin 2 and Monoclonal antibody. His work on Neovascularization as part of general Angiogenesis research is often related to Kinase insert domain receptor and Endoglin, thus linking different fields of science. His study looks at the relationship between Antigen and topics such as Antibody, which overlap with Fusion protein.
His main research concerns Cancer research, Immunology, Angiogenesis, Metastasis and Immunotherapy. His Cancer research research includes themes of Legumain and Carcinogenesis, Cancer, Breast cancer. The study incorporates disciplines such as Receptor, Melanoma, Neuroblastoma and In vivo in addition to Immunology.
His Neuroblastoma study incorporates themes from Oncology, Natural killer cell, Internal medicine, Interleukin 2 and Monoclonal antibody. He has researched Interleukin 2 in several fields, including Antibody and Ratón. His work carried out in the field of Angiogenesis brings together such families of science as Cytotoxic T cell, Endothelium, Radiation therapy and DNA vaccination.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Disk Electrophoresis of Basic Proteins and Peptides on Polyacrylamide Gels
R A Reisfeld;U J Lewis;D E Williams.
Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Peter C. Brooks;Anthony M.P. Montgomery;Mauricio Rosenfeld;Ralph A. Reisfeld.
A procedure for rapid and sensitive staining of protein fractionated by polyacrylamide gel electrophoresis
A. Chrambach;R.A. Reisfeld;M. Wyckoff;J. Zaccari.
Analytical Biochemistry (1967)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma
Alice L. Yu;Andrew L. Gilman;M. Fevzi Ozkaynak;Wendy B. London.
The New England Journal of Medicine (2010)
Tumor Regression by Targeted Gene Delivery to the Neovasculature
John D. Hood;Mark Bednarski;Ricardo Frausto;Samira Guccione.
Antibody targeted drugs as cancer therapeutics
David Schrama;Ralph A. Reisfeld;Jürgen C. Becker.
Nature Reviews Drug Discovery (2006)
DISC ELECTROPHORESIS IN POLYACRYLAMIDE GELS: EXTENSION TO NEW CONDITIONS OF PH AND BUFFER.
Donald E. Williams;Ralph A. Reisfeld.
Annals of the New York Academy of Sciences (2006)
Protein iodination with solid state lactoperoxidase.
Gary S. David;Ralph A. Reisfeld.
Targeting tumor-associated macrophages as a novel strategy against breast cancer
Yunping Luo;He Zhou;Jörg Krueger;Charles Kaplan.
Journal of Clinical Investigation (2006)
Targeting tumor-associated fibroblasts improves cancer chemotherapy by increasing intratumoral drug uptake
Markus Loeffler;Jörg A. Krüger;Andreas G. Niethammer;Ralph A. Reisfeld.
Journal of Clinical Investigation (2006)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: